One year after the United States announced its withdrawal from the World Health Organization, a former WHO Headquarters Staff Association President reflects on how presence, governance, and leadership shape influence in global health. In January 2024, I stood before the WHO’s Executive Board, chaired by Qatar’s Minister of Health, Dr. Hanan Mohammed Al Kuwari. I […] Continue reading ->
A controversial trial to examine various impacts of the hepatitis B vaccine on newborn babies in Guinea-Bissau has been “suspended or cancelled”, the country’s Health Minister, Quinhim Nanthote, told a media briefing convened by the Africa Centres for Disease Control and Prevention (Africa CDC) on Thursday. This is despite recent assertions by the US Health […] Continue reading ->
STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading ->
The World Health Organization (WHO) negotiations on the world’s first Pathogen Access and Benefit Sharing (PABS) system resumed in Geneva on Tuesday – with only two more weeks of formal negotiations left before the May deadline. Symbolically, this week’s talks resumed on the first anniversary of US President Donald Trump’s announcement that his country would […] Continue reading ->
One year ago today (20 January), the Trump administration exploded the global health sector by immediately “pausing” all aid for 90 days – and dispensing with 83% of US Agency for International Development (USAID) projects six weeks later. Trillionaire Elon Musk and his Department of Government Efficiency (DOGE) “chainsawed” at USAID projects and contracts, folding […] Continue reading ->
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading ->
The $9.4 billion package agreed to by the US Senate and House Appropriations Committees, is more than double the $3.7 billion requested by the Trump Administration, and signals bipartisan support for maintaining significant global health aid – although the package still must be approved by both Senate and House, and could also be vetoed by […] Continue reading ->